OBP-AI-001

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameOBP-AI-001

Drug Alias NameOBP-AI1OBP-AI-001

ClassificationSmall molecules

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOncolys Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOncolys Biopharma Inc

Active IndicationsN/A

Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A

Related LinksN/A